Anna A. Poddubskaya
Anna A. Poddubskaya has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anna A. Gamaleya
N. N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia
5 shared publications - Аleksey A. Tomskiy
N.N. Burdenko National Medcial Research Center of Neurosurgery Moscow Russia
5 shared publications - Ekaterina V. Bril
State Scientific Centre of the Russian Federation – Federal Medical Biophysical Centre n. a. A. I. Burnazyan; Russian Medical Academy of Continuous Professional Education
4 shared publications - Natalia V. Fedorova
Russian Medical Academy of Continuous Professional Education
4 shared publications - Alexey Sedov
N.N. Semenov Federal Research Center for Chemical Physics Russian Academy of Sciences Moscow Russia
2 shared publications - Dmytriy G. Kesarev
A.I. Burnazyan Federal Medical and Biophysical Center
2 shared publications
Latest Publications
- 6 March 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (2) , 21-27
Pathomorphosis of the Parkinson’s disease against the background of DBS STN
Objectives. To study the clinical pathomorphosis of Parkinson’s disease (PD) against the background of stimulation of the subthalamic nucleus (DBS STN). Material and methods: We present a 15-year analysis of 401 patients with PD in two groups: DBS STN (n=233) and drug therapy group (n=168). In order to study the clinical pathomorphism of the disease, an analysis of the dynamics of the main motor symptoms of PD was carried out using the UPDRS scale, as well as an analysis of the survival of patients in both groups. Results. DBS STN significantly improved motor symptoms in patients with PD during the off period by 57.3% by year 1, by 23.7% by year 15. According to this indicator, patients did not reach the preoperative level. During the inclusion period in this group, the improvement was 40%, the indicator remained stable for 3 years, however, due to the progression of the disease, by the 15th year the deterioration was 20.9%. In the group of patients receiving only drug therapy, there was a progressive worsening of motor symptoms in the off period by 67.5% by the 15th year of observation, in the on period 64.5% (p<0.05). Univariate survival analysis showed that patients receiving STN—DBS had significantly longer survival than those receiving medical treatment alone (p=0.008). Conclusion. DBS STN changes the clinical pathomorphosis of Parkinson’s disease, leading to less severity of parkinsonian symptoms and greater survival of this group of patients.
- 6 March 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (2) , 21-27
Pathomorphosis of the Parkinson’s disease against the background of DBS STN
Objectives. To study the clinical pathomorphosis of Parkinson’s disease (PD) against the background of stimulation of the subthalamic nucleus (DBS STN). Material and methods: We present a 15-year analysis of 401 patients with PD in two groups: DBS STN (n=233) and drug therapy group (n=168). In order to study the clinical pathomorphism of the disease, an analysis of the dynamics of the main motor symptoms of PD was carried out using the UPDRS scale, as well as an analysis of the survival of patients in both groups. Results. DBS STN significantly improved motor symptoms in patients with PD during the off period by 57.3% by year 1, by 23.7% by year 15. According to this indicator, patients did not reach the preoperative level. During the inclusion period in this group, the improvement was 40%, the indicator remained stable for 3 years, however, due to the progression of the disease, by the 15th year the deterioration was 20.9%. In the group of patients receiving only drug therapy, there was a progressive worsening of motor symptoms in the off period by 67.5% by the 15th year of observation, in the on period 64.5% (p<0.05). Univariate survival analysis showed that patients receiving STN—DBS had significantly longer survival than those receiving medical treatment alone (p=0.008). Conclusion. DBS STN changes the clinical pathomorphosis of Parkinson’s disease, leading to less severity of parkinsonian symptoms and greater survival of this group of patients.
- Open Access
- 3 October 2024
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 18 (3) , 91-102
Deep Brain Stimulation Withdrawal Syndrome, a Rare Life-Threatening Condition in Neurology and Neurosurgery
The article addresses an acute condition associated with an abrupt cessation of neurostimulation of deep brain structures, which is manifested by acute hypokinesia and rigidity with further development of akinesia, anarthria and dysphagia. This may result in the need for emergency hospitalization and admission to an intensive care unit. The article presents literature review and clinical case reports. We discuss causes and approaches to the prevention and management of acute decompensation in patients with Parkinson's disease associated with abrupt deep brain stimulation cessation.
- 3 October 2024
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 18 (3) , 91-102
Open AccessDeep Brain Stimulation Withdrawal Syndrome, a Rare Life-Threatening Condition in Neurology and Neurosurgery
The article addresses an acute condition associated with an abrupt cessation of neurostimulation of deep brain structures, which is manifested by acute hypokinesia and rigidity with further development of akinesia, anarthria and dysphagia. This may result in the need for emergency hospitalization and admission to an intensive care unit. The article presents literature review and clinical case reports. We discuss causes and approaches to the prevention and management of acute decompensation in patients with Parkinson's disease associated with abrupt deep brain stimulation cessation.
- Open Access
- 30 June 2022
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 16 (2) , 89-99
Current understanding of neurostimulation for Parkinson's disease
Specific mechanisms underlying the therapeutic effects of neurostimulation in Parkinson's disease remain a topic of discussion and intense study. Understanding these mechanisms can serve as the foundation for developing and selecting more effective parameters to relieve the symptoms of Parkinson's disease, maximize the advantages, and reduce the adverse effects and need for surgical intervention. The article discusses existing models of motor control in the basal ganglia in healthy individuals and in PD from the point of view of neuromodulation (changes in the impulse flow model, oscillatory model), as well as the current understanding of the mechanisms of action of deep brain stimulation (DBS): the block depolarization hypothesis, neural interference hypothesis, synaptic depression hypothesis, synaptic modulation hypothesis, and the DBS astrocytes hypothesis. Factors such as DBS location and neurostimulation parameters, affecting the clinical outcome, are considered in detail. The neuroprotective effect of DBS is also touched on.
- 30 June 2022
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 16 (2) , 89-99
Open AccessCurrent understanding of neurostimulation for Parkinson's disease
Specific mechanisms underlying the therapeutic effects of neurostimulation in Parkinson's disease remain a topic of discussion and intense study. Understanding these mechanisms can serve as the foundation for developing and selecting more effective parameters to relieve the symptoms of Parkinson's disease, maximize the advantages, and reduce the adverse effects and need for surgical intervention. The article discusses existing models of motor control in the basal ganglia in healthy individuals and in PD from the point of view of neuromodulation (changes in the impulse flow model, oscillatory model), as well as the current understanding of the mechanisms of action of deep brain stimulation (DBS): the block depolarization hypothesis, neural interference hypothesis, synaptic depression hypothesis, synaptic modulation hypothesis, and the DBS astrocytes hypothesis. Factors such as DBS location and neurostimulation parameters, affecting the clinical outcome, are considered in detail. The neuroprotective effect of DBS is also touched on.
- Open Access
- 15 January 2022
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 16 (1) , 46-52
Bilateral stimulation of the subthalamic nucleus under local and general anaesthesia
Introduction. Bilateral stimulation of the subthalamic nucleus (STN) is successfully used to treat advanced stages of Parkinson's disease. The standard surgical technique includes microelectrode recording and intraoperative stimulation. The introduction of 3T MRI into clinical practice and new impulse sequences have led to the question of whether the surgery can be performed under general anaesthesia. Aim of the study: to compare the efficacy and safety of bilateral stimulation of STN in patients with Parkinson's disease, using 3T MRI under local and general anaesthesia. Materials and methods. This prospective, randomized controlled study included 40 patients, who underwent electrode implantation using 3T MRI. The patients in the main group (n = 20) had electrodes implanted under general anaesthesia, while the control group (n = 20) had local anaesthesia, intraoperative stimulation and microelectrode recording. The patients motor status, quality of life, cognitive function and required levodopa dose were evaluated after 6 months. Results. The results of 6 months of stimulation were obtained from 30 patients (15 from the main group and 15 from the control group). Reduced motor impairment was observed in both groups as measured on the UPDRS III scale during the 'off' time, with a reduction of 68.7% in the main group and 74.7% in the control group. Improved quality of life, reduced drug-induced motor complications and a reduction in the levodopa dose were also comparable in both groups. No intraoperative haemorrhagic complications were recorded during the study. Conclusions. Preliminary analysis of the data showed that with high-quality visualization of the STN, electrode implantation under anaesthesia is equally effective to awake surgery.
- 15 January 2022
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 16 (1) , 46-52
Open AccessBilateral stimulation of the subthalamic nucleus under local and general anaesthesia
Introduction. Bilateral stimulation of the subthalamic nucleus (STN) is successfully used to treat advanced stages of Parkinson's disease. The standard surgical technique includes microelectrode recording and intraoperative stimulation. The introduction of 3T MRI into clinical practice and new impulse sequences have led to the question of whether the surgery can be performed under general anaesthesia. Aim of the study: to compare the efficacy and safety of bilateral stimulation of STN in patients with Parkinson's disease, using 3T MRI under local and general anaesthesia. Materials and methods. This prospective, randomized controlled study included 40 patients, who underwent electrode implantation using 3T MRI. The patients in the main group (n = 20) had electrodes implanted under general anaesthesia, while the control group (n = 20) had local anaesthesia, intraoperative stimulation and microelectrode recording. The patients motor status, quality of life, cognitive function and required levodopa dose were evaluated after 6 months. Results. The results of 6 months of stimulation were obtained from 30 patients (15 from the main group and 15 from the control group). Reduced motor impairment was observed in both groups as measured on the UPDRS III scale during the 'off' time, with a reduction of 68.7% in the main group and 74.7% in the control group. Improved quality of life, reduced drug-induced motor complications and a reduction in the levodopa dose were also comparable in both groups. No intraoperative haemorrhagic complications were recorded during the study. Conclusions. Preliminary analysis of the data showed that with high-quality visualization of the STN, electrode implantation under anaesthesia is equally effective to awake surgery.
- Open Access
- 4 October 2021
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 15 (3) , 43-53
Analysing the reasons for rejection of neurosurgery intervention in patients with Parkinson’s disease referred to an extrapyramidal movement disorders clinic
We present findings of a 10-year retrospective study, analysing the reasons for rejection of neurosurgical intervention (deep brain stimulation or DBS) in patients with Parkinsons disease, who were referred to an extrapyramidal movement disorders clinic and then to a neurosurgery centre. It was found that after screening, 78.6% of patients referred as candidates for neurosurgical treatment to an extrapyramidal movement disorders clinic were rejected, while 21.4% of patients were referred to a neurosurgery centre, where 12% underwent surgery. The main reasons for rejecting potential DBS candidates were: early referral, inadequate pharmacotherapy, levodopa-resistant symptoms, atypical/secondary Parkinsonism, cognitive reasons, psychological reasons, comorbidity, abnormal MRI, poor response to levodopa medication and declined surgery. Furthermore, the number of self-referrals decreased, the number of patients referred by neurologists increased, the number of rejections of unsuitable DBS candidates decreased, and the number of suitable candidates referred to the extrapyramidal centre increased during the time period of 10 years. In addition, the number of patients who were referred to the neurosurgery centre and underwent surgery there increased, which suggests greater awareness of the selection criteria among doctors, as well increased knowledge and experience among neurologists in both primary healthcare and specialized centres.
- 4 October 2021
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 15 (3) , 43-53
Open AccessAnalysing the reasons for rejection of neurosurgery intervention in patients with Parkinson’s disease referred to an extrapyramidal movement disorders clinic
We present findings of a 10-year retrospective study, analysing the reasons for rejection of neurosurgical intervention (deep brain stimulation or DBS) in patients with Parkinsons disease, who were referred to an extrapyramidal movement disorders clinic and then to a neurosurgery centre. It was found that after screening, 78.6% of patients referred as candidates for neurosurgical treatment to an extrapyramidal movement disorders clinic were rejected, while 21.4% of patients were referred to a neurosurgery centre, where 12% underwent surgery. The main reasons for rejecting potential DBS candidates were: early referral, inadequate pharmacotherapy, levodopa-resistant symptoms, atypical/secondary Parkinsonism, cognitive reasons, psychological reasons, comorbidity, abnormal MRI, poor response to levodopa medication and declined surgery. Furthermore, the number of self-referrals decreased, the number of patients referred by neurologists increased, the number of rejections of unsuitable DBS candidates decreased, and the number of suitable candidates referred to the extrapyramidal centre increased during the time period of 10 years. In addition, the number of patients who were referred to the neurosurgery centre and underwent surgery there increased, which suggests greater awareness of the selection criteria among doctors, as well increased knowledge and experience among neurologists in both primary healthcare and specialized centres.
- Open Access
- 24 March 2018
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1
Dynamics of cognitive functions in the early postoperative period after spinal neurosurgical operations
The aim of the study was to study cognitive changes in the early postoperative period after spinal neurosurgical operations. Material and methods. 80 patients were operated with spinal pathology. The patients were divided into two groups: the 1st group consisted of 40 patients under the age of 60 (mean age 42 ± 11.6), the second group consisted of 40 patients aged 60 years and older (mean age was 68 ± 9.77). Various methods of anesthesia were used in the work. Neuropsychological examination in accordance with the general clinical protocol before the operation and 5–7 days after the operation. The following factors for evaluation were chosen: duration of anesthesia, hemodynamics, anesthesia method and type of anesthetic, monitoring of the depth of anesthesia using BIS technology. Results. Patients ≥ 60 years before the operation had cognitive changes in working memory and regulatory functions aggravated in the postoperative period. With short anesthesia (< 200 minutes), significant differences in test results before and after surgery were not obtained. Prolonged anesthesia (≥ 200 minutes) has negative effects on cognitive functions based on the results of the working memory test and MOCA. A greater decrease in neurodynamic parameters and MOCA scores is observed with the intravenous propofol anesthesia compared with an inhaled anesthesia with sevoflurane.
- 24 March 2018
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1
Open AccessDynamics of cognitive functions in the early postoperative period after spinal neurosurgical operations
The aim of the study was to study cognitive changes in the early postoperative period after spinal neurosurgical operations. Material and methods. 80 patients were operated with spinal pathology. The patients were divided into two groups: the 1st group consisted of 40 patients under the age of 60 (mean age 42 ± 11.6), the second group consisted of 40 patients aged 60 years and older (mean age was 68 ± 9.77). Various methods of anesthesia were used in the work. Neuropsychological examination in accordance with the general clinical protocol before the operation and 5–7 days after the operation. The following factors for evaluation were chosen: duration of anesthesia, hemodynamics, anesthesia method and type of anesthetic, monitoring of the depth of anesthesia using BIS technology. Results. Patients ≥ 60 years before the operation had cognitive changes in working memory and regulatory functions aggravated in the postoperative period. With short anesthesia (< 200 minutes), significant differences in test results before and after surgery were not obtained. Prolonged anesthesia (≥ 200 minutes) has negative effects on cognitive functions based on the results of the working memory test and MOCA. A greater decrease in neurodynamic parameters and MOCA scores is observed with the intravenous propofol anesthesia compared with an inhaled anesthesia with sevoflurane.